September 19, 2023 Comments Off on New patent for Neurocrine drug INGREZZA Posted in: Patent Added Annual Drug Patent Expirations for INGREZZA Ingrezza is a drug marketed by Neurocrine and is included in one NDA. It is available from one supplier. There are twenty patents protecting…
The post New patent for Neurocrine drug INGREZZA appeared first on…
September 19, 2023 Comments Off on New patent for Axsome drug AUVELITY Posted in: Patent Added Annual Drug Patent Expirations for AUVELITY Auvelity is a drug marketed by Axsome and is included in one NDA. It is available from one supplier. There are one hundred and…
The post New patent for Axsome drug AUVELITY appeared first on DrugPatentWatch -…
